Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2017 Dec 14;118(5):629–633. doi: 10.1038/bjc.2017.448

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Cancer Research UK

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/

PMC Copyright notice

Kaplan-Meier plots for NSABP/NRG Oncology C-07 patients stratified by sidedness (left vs right) and treatment (5-fluorouracil (5-FU) plus leucovorin (LV) vs 5-FU+LV and oxaliplatin (FLOX)) in: (A) stage III patients based on RFS, (B) stage III patients based on OS, (C) stage III enterocyte-subtype patients based on RFS, (D) stage III other-subtype patients based on RFS, (E) stage III enterocyte-subtype patients based on OS, and (F) stage III other-subtype patients based on OS. The number of patients at risk is shown below the graph.